Selected Papers from 2017 Chinese Medicinal Chemistry Symposium (CMCS 2017)
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 October 2017)
Special Issue Editor
Interests: design and synthesis of bioactive compound; synthesis and modification of natural product; drugability optimization
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The 2017 Chinese Medicinal Chemistry Symposium (CMCS 2017) will be held, 27–30 August, 2017, in Beijing, China. It is the highest scientific event for the Chinese medicinal chemistry research field, aiming to provide a high-level platform for the discussion and exchange of the latest developments in medicinal chemistry and related fields, for researchers and the business community. According to the signed cooperation framework agreement between the Chinese Pharmaceutical Association and the European Federation for Medicinal Chemistry, the 2017 CPA-EFMC International Symposium on Medicinal Chemistry will be held in the same period.
The topic of this symposium is “Committing to New Global Medicine Research and Development—Focusing on New Molecules, Technologies, and Therapies”. The symposium will provide a good communication platform for researchers of medicinal chemistry and related fields, enhancing communication and cooperation, and promoting the development and application of medicinal chemistry. Thus, we set up this Special Issue to provide a global platform for presenting the latest research results in medicinal chemistry-related areas.
In this Special Issue, we welcome original articles and short communications, as well as a limited number of review articles, which present the most advanced medicinal chemistry-related research results, including, but not limited to, novel biological active molecules, novel screening and design methods, and new therapeutic strategies.
Prof. Dr. Qi-Dong You
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- new drug discovery
- rational design
- drug design methodology
- synthetic methodology for new medicinal compounds
- medicinal chemical biology
- natural product chemistry
